nodes	percent_of_prediction	percent_of_DWPC	metapath
Timolol—ADRB1—dilated cardiomyopathy	0.425	0.543	CbGaD
Timolol—ADRB2—dilated cardiomyopathy	0.358	0.457	CbGaD
Timolol—ABCB1—Lisinopril—dilated cardiomyopathy	0.0592	0.532	CbGbCtD
Timolol—ABCB1—Spironolactone—dilated cardiomyopathy	0.0521	0.468	CbGbCtD
Timolol—Common cold—Lisinopril—dilated cardiomyopathy	0.00291	0.0405	CcSEcCtD
Timolol—Rash erythematous—Spironolactone—dilated cardiomyopathy	0.00243	0.0339	CcSEcCtD
Timolol—ADRB3—Adrenoceptors—ADRB1—dilated cardiomyopathy	0.00228	0.0854	CbGpPWpGaD
Timolol—ADRB3—Adrenoceptors—ADRB2—dilated cardiomyopathy	0.00185	0.0692	CbGpPWpGaD
Timolol—Levobunolol—ADRB1—dilated cardiomyopathy	0.00165	0.228	CrCbGaD
Timolol—Cerebral ischaemia—Lisinopril—dilated cardiomyopathy	0.00157	0.0219	CcSEcCtD
Timolol—Levobunolol—ADRB2—dilated cardiomyopathy	0.00139	0.192	CrCbGaD
Timolol—ADRB2—Adrenoceptors—ADRB1—dilated cardiomyopathy	0.00132	0.0496	CbGpPWpGaD
Timolol—Psoriasis—Lisinopril—dilated cardiomyopathy	0.00121	0.0168	CcSEcCtD
Timolol—Bupranolol—ADRB1—dilated cardiomyopathy	0.00119	0.165	CrCbGaD
Timolol—ADRB1—Adrenoceptors—ADRB2—dilated cardiomyopathy	0.0011	0.041	CbGpPWpGaD
Timolol—Penbutolol—ADRB1—dilated cardiomyopathy	0.00109	0.151	CrCbGaD
Timolol—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.00107	0.015	CcSEcCtD
Timolol—Throat sore—Lisinopril—dilated cardiomyopathy	0.00105	0.0147	CcSEcCtD
Timolol—Oropharyngeal discomfort—Lisinopril—dilated cardiomyopathy	0.00104	0.0146	CcSEcCtD
Timolol—Bupranolol—ADRB2—dilated cardiomyopathy	0.001	0.139	CrCbGaD
Timolol—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.00097	0.0135	CcSEcCtD
Timolol—Rhinorrhoea—Lisinopril—dilated cardiomyopathy	0.000937	0.0131	CcSEcCtD
Timolol—Penbutolol—ADRB2—dilated cardiomyopathy	0.000919	0.127	CrCbGaD
Timolol—Oropharyngeal pain—Lisinopril—dilated cardiomyopathy	0.000834	0.0116	CcSEcCtD
Timolol—Arthropathy—Lisinopril—dilated cardiomyopathy	0.000834	0.0116	CcSEcCtD
Timolol—Alopecia—Spironolactone—dilated cardiomyopathy	0.000825	0.0115	CcSEcCtD
Timolol—ADRB3—Monoamine GPCRs—ADRB1—dilated cardiomyopathy	0.000806	0.0302	CbGpPWpGaD
Timolol—Dermatitis exfoliative—Furosemide—dilated cardiomyopathy	0.000778	0.0109	CcSEcCtD
Timolol—Blood urea increased—Lisinopril—dilated cardiomyopathy	0.000716	0.00999	CcSEcCtD
Timolol—Photophobia—Lisinopril—dilated cardiomyopathy	0.000712	0.00994	CcSEcCtD
Timolol—Discomfort—Spironolactone—dilated cardiomyopathy	0.000684	0.00953	CcSEcCtD
Timolol—ADRB3—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.000677	0.0254	CbGpPWpGaD
Timolol—Pulmonary oedema—Lisinopril—dilated cardiomyopathy	0.000675	0.00942	CcSEcCtD
Timolol—Confusional state—Spironolactone—dilated cardiomyopathy	0.000669	0.00933	CcSEcCtD
Timolol—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.000663	0.00925	CcSEcCtD
Timolol—ADRB3—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.000653	0.0245	CbGpPWpGaD
Timolol—Nasal congestion—Lisinopril—dilated cardiomyopathy	0.000605	0.00843	CcSEcCtD
Timolol—Libido decreased—Lisinopril—dilated cardiomyopathy	0.000594	0.00828	CcSEcCtD
Timolol—Somnolence—Spironolactone—dilated cardiomyopathy	0.00059	0.00822	CcSEcCtD
Timolol—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.000573	0.00799	CcSEcCtD
Timolol—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.000572	0.00798	CcSEcCtD
Timolol—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.000564	0.00787	CcSEcCtD
Timolol—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.000562	0.00784	CcSEcCtD
Timolol—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.000551	0.00768	CcSEcCtD
Timolol—Diplopia—Lisinopril—dilated cardiomyopathy	0.000551	0.00768	CcSEcCtD
Timolol—Pain in extremity—Lisinopril—dilated cardiomyopathy	0.000551	0.00768	CcSEcCtD
Timolol—ADRB3—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.000549	0.0206	CbGpPWpGaD
Timolol—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.000547	0.00762	CcSEcCtD
Timolol—Disturbance in sexual arousal—Lisinopril—dilated cardiomyopathy	0.000546	0.00762	CcSEcCtD
Timolol—Sweating—Furosemide—dilated cardiomyopathy	0.000542	0.00756	CcSEcCtD
Timolol—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.000528	0.00736	CcSEcCtD
Timolol—Urticaria—Spironolactone—dilated cardiomyopathy	0.000527	0.00735	CcSEcCtD
Timolol—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.000524	0.00731	CcSEcCtD
Timolol—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.000524	0.0073	CcSEcCtD
Timolol—ADRB3—Calcium Regulation in the Cardiac Cell—RYR2—dilated cardiomyopathy	0.00051	0.0191	CbGpPWpGaD
Timolol—Breast disorder—Lisinopril—dilated cardiomyopathy	0.000498	0.00694	CcSEcCtD
Timolol—ADRB3—Calcium Regulation in the Cardiac Cell—PLN—dilated cardiomyopathy	0.000496	0.0186	CbGpPWpGaD
Timolol—Nasopharyngitis—Lisinopril—dilated cardiomyopathy	0.000493	0.00687	CcSEcCtD
Timolol—Visual impairment—Furosemide—dilated cardiomyopathy	0.000489	0.00683	CcSEcCtD
Timolol—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.000489	0.00681	CcSEcCtD
Timolol—Asthma—Lisinopril—dilated cardiomyopathy	0.000476	0.00664	CcSEcCtD
Timolol—Eye disorder—Furosemide—dilated cardiomyopathy	0.000475	0.00662	CcSEcCtD
Timolol—Tinnitus—Furosemide—dilated cardiomyopathy	0.000474	0.0066	CcSEcCtD
Timolol—Pruritus—Spironolactone—dilated cardiomyopathy	0.000469	0.00654	CcSEcCtD
Timolol—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.000468	0.00653	CcSEcCtD
Timolol—ADRB2—Monoamine GPCRs—ADRB1—dilated cardiomyopathy	0.000468	0.0175	CbGpPWpGaD
Timolol—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.000464	0.00647	CcSEcCtD
Timolol—Angiopathy—Furosemide—dilated cardiomyopathy	0.000461	0.00643	CcSEcCtD
Timolol—Immune system disorder—Furosemide—dilated cardiomyopathy	0.000459	0.0064	CcSEcCtD
Timolol—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000454	0.00633	CcSEcCtD
Timolol—Arrhythmia—Furosemide—dilated cardiomyopathy	0.000454	0.00633	CcSEcCtD
Timolol—Dysuria—Lisinopril—dilated cardiomyopathy	0.000445	0.00621	CcSEcCtD
Timolol—ABCB1—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.000443	0.0166	CbGpPWpGaD
Timolol—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.000442	0.00617	CcSEcCtD
Timolol—Malnutrition—Furosemide—dilated cardiomyopathy	0.000442	0.00617	CcSEcCtD
Timolol—Erythema—Furosemide—dilated cardiomyopathy	0.000442	0.00617	CcSEcCtD
Timolol—Dizziness—Spironolactone—dilated cardiomyopathy	0.000439	0.00612	CcSEcCtD
Timolol—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.000438	0.00611	CcSEcCtD
Timolol—Dysgeusia—Furosemide—dilated cardiomyopathy	0.000433	0.00604	CcSEcCtD
Timolol—Weight decreased—Lisinopril—dilated cardiomyopathy	0.000431	0.00601	CcSEcCtD
Timolol—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.000429	0.00599	CcSEcCtD
Timolol—Depression—Lisinopril—dilated cardiomyopathy	0.000423	0.0059	CcSEcCtD
Timolol—Vomiting—Spironolactone—dilated cardiomyopathy	0.000422	0.00588	CcSEcCtD
Timolol—Rash—Spironolactone—dilated cardiomyopathy	0.000418	0.00583	CcSEcCtD
Timolol—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000418	0.00583	CcSEcCtD
Timolol—Vision blurred—Furosemide—dilated cardiomyopathy	0.000417	0.00581	CcSEcCtD
Timolol—Headache—Spironolactone—dilated cardiomyopathy	0.000415	0.00579	CcSEcCtD
Timolol—ADRB3—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.000411	0.0154	CbGpPWpGaD
Timolol—Sweating—Lisinopril—dilated cardiomyopathy	0.000407	0.00568	CcSEcCtD
Timolol—Epistaxis—Lisinopril—dilated cardiomyopathy	0.0004	0.00558	CcSEcCtD
Timolol—Sinusitis—Lisinopril—dilated cardiomyopathy	0.000398	0.00555	CcSEcCtD
Timolol—Vertigo—Furosemide—dilated cardiomyopathy	0.000397	0.00554	CcSEcCtD
Timolol—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.000396	0.00552	CcSEcCtD
Timolol—Nausea—Spironolactone—dilated cardiomyopathy	0.000394	0.00549	CcSEcCtD
Timolol—ADRB2—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.000393	0.0147	CbGpPWpGaD
Timolol—Bradycardia—Lisinopril—dilated cardiomyopathy	0.000388	0.00541	CcSEcCtD
Timolol—ADRB1—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.000387	0.0145	CbGpPWpGaD
Timolol—Rhinitis—Lisinopril—dilated cardiomyopathy	0.000382	0.00533	CcSEcCtD
Timolol—ADRB2—Arf6 signaling events—AGTR1—dilated cardiomyopathy	0.000381	0.0143	CbGpPWpGaD
Timolol—Hallucination—Lisinopril—dilated cardiomyopathy	0.000379	0.00529	CcSEcCtD
Timolol—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.000375	0.00524	CcSEcCtD
Timolol—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.000374	0.00521	CcSEcCtD
Timolol—Dry mouth—Furosemide—dilated cardiomyopathy	0.000368	0.00513	CcSEcCtD
Timolol—Confusional state—Furosemide—dilated cardiomyopathy	0.000364	0.00507	CcSEcCtD
Timolol—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.000361	0.00503	CcSEcCtD
Timolol—Tinnitus—Lisinopril—dilated cardiomyopathy	0.000355	0.00495	CcSEcCtD
Timolol—Shock—Furosemide—dilated cardiomyopathy	0.000355	0.00495	CcSEcCtD
Timolol—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.000354	0.00493	CcSEcCtD
Timolol—Skin disorder—Furosemide—dilated cardiomyopathy	0.00035	0.00489	CcSEcCtD
Timolol—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000349	0.00486	CcSEcCtD
Timolol—Angiopathy—Lisinopril—dilated cardiomyopathy	0.000346	0.00482	CcSEcCtD
Timolol—Anorexia—Furosemide—dilated cardiomyopathy	0.000344	0.0048	CcSEcCtD
Timolol—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.000343	0.00479	CcSEcCtD
Timolol—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.00034	0.00475	CcSEcCtD
Timolol—Hypotension—Furosemide—dilated cardiomyopathy	0.000337	0.0047	CcSEcCtD
Timolol—Alopecia—Lisinopril—dilated cardiomyopathy	0.000337	0.0047	CcSEcCtD
Timolol—Mental disorder—Lisinopril—dilated cardiomyopathy	0.000334	0.00466	CcSEcCtD
Timolol—Erythema—Lisinopril—dilated cardiomyopathy	0.000332	0.00463	CcSEcCtD
Timolol—Malnutrition—Lisinopril—dilated cardiomyopathy	0.000332	0.00463	CcSEcCtD
Timolol—ADRB1—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.000326	0.0122	CbGpPWpGaD
Timolol—Tension—Lisinopril—dilated cardiomyopathy	0.000326	0.00454	CcSEcCtD
Timolol—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.000325	0.00453	CcSEcCtD
Timolol—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000324	0.00452	CcSEcCtD
Timolol—Nervousness—Lisinopril—dilated cardiomyopathy	0.000322	0.00449	CcSEcCtD
Timolol—Somnolence—Furosemide—dilated cardiomyopathy	0.000321	0.00447	CcSEcCtD
Timolol—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000314	0.00437	CcSEcCtD
Timolol—Vision blurred—Lisinopril—dilated cardiomyopathy	0.000313	0.00436	CcSEcCtD
Timolol—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000312	0.00434	CcSEcCtD
Timolol—Fatigue—Furosemide—dilated cardiomyopathy	0.000311	0.00434	CcSEcCtD
Timolol—Pain—Furosemide—dilated cardiomyopathy	0.000309	0.0043	CcSEcCtD
Timolol—Angioedema—Lisinopril—dilated cardiomyopathy	0.000303	0.00423	CcSEcCtD
Timolol—ADRB1—Calcium Regulation in the Cardiac Cell—RYR2—dilated cardiomyopathy	0.000303	0.0113	CbGpPWpGaD
Timolol—ADRB2—Arf6 trafficking events—AGTR1—dilated cardiomyopathy	0.000301	0.0113	CbGpPWpGaD
Timolol—Vertigo—Lisinopril—dilated cardiomyopathy	0.000298	0.00416	CcSEcCtD
Timolol—Syncope—Lisinopril—dilated cardiomyopathy	0.000297	0.00415	CcSEcCtD
Timolol—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000297	0.00415	CcSEcCtD
Timolol—ADRB2—Calcium Regulation in the Cardiac Cell—RYR2—dilated cardiomyopathy	0.000296	0.0111	CbGpPWpGaD
Timolol—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000295	0.00411	CcSEcCtD
Timolol—ADRB1—Calcium Regulation in the Cardiac Cell—PLN—dilated cardiomyopathy	0.000294	0.011	CbGpPWpGaD
Timolol—Palpitations—Lisinopril—dilated cardiomyopathy	0.000293	0.00409	CcSEcCtD
Timolol—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.000292	0.00407	CcSEcCtD
Timolol—Cough—Lisinopril—dilated cardiomyopathy	0.000289	0.00404	CcSEcCtD
Timolol—ADRB2—Calcium Regulation in the Cardiac Cell—PLN—dilated cardiomyopathy	0.000288	0.0108	CbGpPWpGaD
Timolol—Urticaria—Furosemide—dilated cardiomyopathy	0.000287	0.004	CcSEcCtD
Timolol—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000285	0.00398	CcSEcCtD
Timolol—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000285	0.00398	CcSEcCtD
Timolol—Chest pain—Lisinopril—dilated cardiomyopathy	0.000282	0.00394	CcSEcCtD
Timolol—Myalgia—Lisinopril—dilated cardiomyopathy	0.000282	0.00394	CcSEcCtD
Timolol—Arthralgia—Lisinopril—dilated cardiomyopathy	0.000282	0.00394	CcSEcCtD
Timolol—CYP2C19—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.000282	0.0106	CbGpPWpGaD
Timolol—Anxiety—Lisinopril—dilated cardiomyopathy	0.000281	0.00392	CcSEcCtD
Timolol—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.00028	0.00391	CcSEcCtD
Timolol—ADRB3—G alpha (s) signalling events—ADRB1—dilated cardiomyopathy	0.000279	0.0105	CbGpPWpGaD
Timolol—Discomfort—Lisinopril—dilated cardiomyopathy	0.000279	0.00389	CcSEcCtD
Timolol—Dry mouth—Lisinopril—dilated cardiomyopathy	0.000276	0.00385	CcSEcCtD
Timolol—ADRB2—Arf6 trafficking events—ITGB1—dilated cardiomyopathy	0.000276	0.0103	CbGpPWpGaD
Timolol—Confusional state—Lisinopril—dilated cardiomyopathy	0.000273	0.00381	CcSEcCtD
Timolol—Oedema—Lisinopril—dilated cardiomyopathy	0.000271	0.00378	CcSEcCtD
Timolol—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.000271	0.00378	CcSEcCtD
Timolol—Infection—Lisinopril—dilated cardiomyopathy	0.000269	0.00375	CcSEcCtD
Timolol—Shock—Lisinopril—dilated cardiomyopathy	0.000266	0.00371	CcSEcCtD
Timolol—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000266	0.00371	CcSEcCtD
Timolol—Skin disorder—Lisinopril—dilated cardiomyopathy	0.000263	0.00367	CcSEcCtD
Timolol—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000262	0.00365	CcSEcCtD
Timolol—CYP2D6—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.00026	0.00973	CbGpPWpGaD
Timolol—Asthenia—Furosemide—dilated cardiomyopathy	0.000259	0.00361	CcSEcCtD
Timolol—Anorexia—Lisinopril—dilated cardiomyopathy	0.000258	0.0036	CcSEcCtD
Timolol—Pruritus—Furosemide—dilated cardiomyopathy	0.000255	0.00356	CcSEcCtD
Timolol—Hypotension—Lisinopril—dilated cardiomyopathy	0.000253	0.00353	CcSEcCtD
Timolol—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000247	0.00344	CcSEcCtD
Timolol—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000247	0.00344	CcSEcCtD
Timolol—Insomnia—Lisinopril—dilated cardiomyopathy	0.000245	0.00341	CcSEcCtD
Timolol—ADRB1—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.000244	0.00914	CbGpPWpGaD
Timolol—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000243	0.00339	CcSEcCtD
Timolol—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000241	0.00337	CcSEcCtD
Timolol—ADRB3—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	0.000241	0.00904	CbGpPWpGaD
Timolol—Somnolence—Lisinopril—dilated cardiomyopathy	0.000241	0.00336	CcSEcCtD
Timolol—ADRB2—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.000239	0.00895	CbGpPWpGaD
Timolol—Dizziness—Furosemide—dilated cardiomyopathy	0.000239	0.00333	CcSEcCtD
Timolol—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000238	0.00332	CcSEcCtD
Timolol—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000235	0.00328	CcSEcCtD
Timolol—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000234	0.00326	CcSEcCtD
Timolol—Fatigue—Lisinopril—dilated cardiomyopathy	0.000233	0.00326	CcSEcCtD
Timolol—Pain—Lisinopril—dilated cardiomyopathy	0.000232	0.00323	CcSEcCtD
Timolol—Vomiting—Furosemide—dilated cardiomyopathy	0.000229	0.0032	CcSEcCtD
Timolol—Rash—Furosemide—dilated cardiomyopathy	0.000228	0.00317	CcSEcCtD
Timolol—Dermatitis—Furosemide—dilated cardiomyopathy	0.000227	0.00317	CcSEcCtD
Timolol—ADRB3—G alpha (s) signalling events—ADRB2—dilated cardiomyopathy	0.000226	0.00848	CbGpPWpGaD
Timolol—Headache—Furosemide—dilated cardiomyopathy	0.000226	0.00315	CcSEcCtD
Timolol—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000223	0.00311	CcSEcCtD
Timolol—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000221	0.00309	CcSEcCtD
Timolol—Urticaria—Lisinopril—dilated cardiomyopathy	0.000215	0.003	CcSEcCtD
Timolol—ADRB2—GPCRs, Other—CXCR3—dilated cardiomyopathy	0.000215	0.00804	CbGpPWpGaD
Timolol—Nausea—Furosemide—dilated cardiomyopathy	0.000214	0.00299	CcSEcCtD
Timolol—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000214	0.00298	CcSEcCtD
Timolol—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000214	0.00298	CcSEcCtD
Timolol—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000199	0.00278	CcSEcCtD
Timolol—ADRB1—Endothelin Pathways—RAF1—dilated cardiomyopathy	0.000199	0.00747	CbGpPWpGaD
Timolol—ADRB3—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	0.000199	0.00746	CbGpPWpGaD
Timolol—ADRB3—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	0.000195	0.00732	CbGpPWpGaD
Timolol—Asthenia—Lisinopril—dilated cardiomyopathy	0.000194	0.00271	CcSEcCtD
Timolol—Pruritus—Lisinopril—dilated cardiomyopathy	0.000192	0.00267	CcSEcCtD
Timolol—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000185	0.00258	CcSEcCtD
Timolol—Dizziness—Lisinopril—dilated cardiomyopathy	0.000179	0.0025	CcSEcCtD
Timolol—ADRB3—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000173	0.00647	CbGpPWpGaD
Timolol—Vomiting—Lisinopril—dilated cardiomyopathy	0.000172	0.0024	CcSEcCtD
Timolol—Rash—Lisinopril—dilated cardiomyopathy	0.000171	0.00238	CcSEcCtD
Timolol—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000171	0.00238	CcSEcCtD
Timolol—Headache—Lisinopril—dilated cardiomyopathy	0.00017	0.00237	CcSEcCtD
Timolol—ADRB2—G alpha (s) signalling events—ADRB1—dilated cardiomyopathy	0.000162	0.00608	CbGpPWpGaD
Timolol—Nausea—Lisinopril—dilated cardiomyopathy	0.000161	0.00224	CcSEcCtD
Timolol—ADRB3—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000161	0.00601	CbGpPWpGaD
Timolol—ADRB3—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000155	0.00583	CbGpPWpGaD
Timolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000148	0.00554	CbGpPWpGaD
Timolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000148	0.00554	CbGpPWpGaD
Timolol—ADRB2—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	0.00014	0.00525	CbGpPWpGaD
Timolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000138	0.00515	CbGpPWpGaD
Timolol—ADRB1—G alpha (s) signalling events—ADRB2—dilated cardiomyopathy	0.000134	0.00503	CbGpPWpGaD
Timolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000133	0.00499	CbGpPWpGaD
Timolol—ADRB3—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000133	0.00498	CbGpPWpGaD
Timolol—ADRB2—Arf6 signaling events—EGFR—dilated cardiomyopathy	0.000128	0.00478	CbGpPWpGaD
Timolol—ADRB3—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000126	0.00472	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.000125	0.0047	CbGpPWpGaD
Timolol—CYP2C19—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000125	0.00469	CbGpPWpGaD
Timolol—ADRB1—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	0.000118	0.00443	CbGpPWpGaD
Timolol—ADRB1—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	0.000116	0.00435	CbGpPWpGaD
Timolol—ADRB2—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	0.000116	0.00433	CbGpPWpGaD
Timolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000114	0.00426	CbGpPWpGaD
Timolol—ADRB3—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000113	0.00422	CbGpPWpGaD
Timolol—ADRB3—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000113	0.00422	CbGpPWpGaD
Timolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000108	0.00404	CbGpPWpGaD
Timolol—ABCB1—Allograft Rejection—AGTR1—dilated cardiomyopathy	0.000106	0.00396	CbGpPWpGaD
Timolol—ADRB3—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000105	0.00392	CbGpPWpGaD
Timolol—ADRB1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000102	0.00384	CbGpPWpGaD
Timolol—ADRB3—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000101	0.0038	CbGpPWpGaD
Timolol—ADRB2—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.0001	0.00376	CbGpPWpGaD
Timolol—ADRB1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	9.53e-05	0.00357	CbGpPWpGaD
Timolol—ADRB2—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	9.32e-05	0.00349	CbGpPWpGaD
Timolol—ADRB2—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	9.03e-05	0.00338	CbGpPWpGaD
Timolol—ABCB1—Allograft Rejection—IL10—dilated cardiomyopathy	8.85e-05	0.00332	CbGpPWpGaD
Timolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	8.78e-05	0.00329	CbGpPWpGaD
Timolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	8.78e-05	0.00329	CbGpPWpGaD
Timolol—ADRB3—GPCR ligand binding—AGTR1—dilated cardiomyopathy	8.66e-05	0.00325	CbGpPWpGaD
Timolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	8.59e-05	0.00322	CbGpPWpGaD
Timolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	8.59e-05	0.00322	CbGpPWpGaD
Timolol—ABCB1—Allograft Rejection—FASLG—dilated cardiomyopathy	8.23e-05	0.00308	CbGpPWpGaD
Timolol—ADRB3—GPCR ligand binding—ADRB2—dilated cardiomyopathy	8.22e-05	0.00308	CbGpPWpGaD
Timolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	8.16e-05	0.00306	CbGpPWpGaD
Timolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	8e-05	0.003	CbGpPWpGaD
Timolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	7.98e-05	0.00299	CbGpPWpGaD
Timolol—ABCB1—Allograft Rejection—FAS—dilated cardiomyopathy	7.93e-05	0.00297	CbGpPWpGaD
Timolol—ADRB1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	7.88e-05	0.00295	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	7.75e-05	0.0029	CbGpPWpGaD
Timolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	7.73e-05	0.0029	CbGpPWpGaD
Timolol—ADRB2—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	7.71e-05	0.00289	CbGpPWpGaD
Timolol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	7.48e-05	0.0028	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	7.28e-05	0.00273	CbGpPWpGaD
Timolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	6.75e-05	0.00253	CbGpPWpGaD
Timolol—ADRB1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	6.69e-05	0.00251	CbGpPWpGaD
Timolol—ADRB1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	6.69e-05	0.00251	CbGpPWpGaD
Timolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	6.6e-05	0.00247	CbGpPWpGaD
Timolol—ADRB2—GPCR ligand binding—CXCL2—dilated cardiomyopathy	6.54e-05	0.00245	CbGpPWpGaD
Timolol—ADRB2—GPCR ligand binding—AGTR2—dilated cardiomyopathy	6.54e-05	0.00245	CbGpPWpGaD
Timolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	6.41e-05	0.0024	CbGpPWpGaD
Timolol—ADRB3—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	6.37e-05	0.00239	CbGpPWpGaD
Timolol—ADRB3—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	6.37e-05	0.00239	CbGpPWpGaD
Timolol—ADRB1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	6.22e-05	0.00233	CbGpPWpGaD
Timolol—ADRB3—GPCR ligand binding—AGT—dilated cardiomyopathy	6.1e-05	0.00228	CbGpPWpGaD
Timolol—ADRB2—GPCR ligand binding—CXCR3—dilated cardiomyopathy	6.08e-05	0.00228	CbGpPWpGaD
Timolol—ADRB3—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	5.92e-05	0.00222	CbGpPWpGaD
Timolol—ADRB2—GPCR ligand binding—ADRB1—dilated cardiomyopathy	5.89e-05	0.00221	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—CXCL2—dilated cardiomyopathy	5.78e-05	0.00217	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—AGTR2—dilated cardiomyopathy	5.78e-05	0.00217	CbGpPWpGaD
Timolol—ADRB3—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	5.73e-05	0.00215	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—CXCR3—dilated cardiomyopathy	5.37e-05	0.00201	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—ADRB1—dilated cardiomyopathy	5.21e-05	0.00195	CbGpPWpGaD
Timolol—ADRB1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	5.14e-05	0.00193	CbGpPWpGaD
Timolol—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	5.12e-05	0.00192	CbGpPWpGaD
Timolol—ADRB2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	5.03e-05	0.00188	CbGpPWpGaD
Timolol—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	4.98e-05	0.00187	CbGpPWpGaD
Timolol—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	4.98e-05	0.00187	CbGpPWpGaD
Timolol—ADRB3—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	4.9e-05	0.00183	CbGpPWpGaD
Timolol—ADRB1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	4.88e-05	0.00183	CbGpPWpGaD
Timolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	4.75e-05	0.00178	CbGpPWpGaD
Timolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	4.65e-05	0.00174	CbGpPWpGaD
Timolol—ADRB3—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	4.64e-05	0.00174	CbGpPWpGaD
Timolol—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	4.63e-05	0.00174	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—AGTR1—dilated cardiomyopathy	4.45e-05	0.00167	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—ADRB2—dilated cardiomyopathy	4.22e-05	0.00158	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	4.06e-05	0.00152	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	3.91e-05	0.00147	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—PSEN2—dilated cardiomyopathy	3.85e-05	0.00144	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	3.84e-05	0.00144	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	3.78e-05	0.00142	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	3.78e-05	0.00142	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	3.7e-05	0.00139	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	3.7e-05	0.00139	CbGpPWpGaD
Timolol—ADRB1—GPCR ligand binding—AGT—dilated cardiomyopathy	3.62e-05	0.00136	CbGpPWpGaD
Timolol—ADRB3—GPCR downstream signaling—RAC1—dilated cardiomyopathy	3.61e-05	0.00135	CbGpPWpGaD
Timolol—ADRB2—GPCR ligand binding—AGT—dilated cardiomyopathy	3.54e-05	0.00133	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	3.51e-05	0.00132	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—ANKRD1—dilated cardiomyopathy	3.45e-05	0.00129	CbGpPWpGaD
Timolol—ADRB3—GPCR downstream signaling—AGT—dilated cardiomyopathy	3.44e-05	0.00129	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	3.44e-05	0.00129	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	3.43e-05	0.00129	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	3.43e-05	0.00129	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—AGTR2—dilated cardiomyopathy	3.42e-05	0.00128	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—CXCL2—dilated cardiomyopathy	3.42e-05	0.00128	CbGpPWpGaD
Timolol—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	3.37e-05	0.00126	CbGpPWpGaD
Timolol—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	3.37e-05	0.00126	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	3.36e-05	0.00126	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	3.36e-05	0.00126	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	3.33e-05	0.00125	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—RAC1—dilated cardiomyopathy	3.27e-05	0.00123	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—TAZ—dilated cardiomyopathy	3.24e-05	0.00122	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	3.19e-05	0.0012	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—CXCR3—dilated cardiomyopathy	3.17e-05	0.00119	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—ANKRD1—dilated cardiomyopathy	3.17e-05	0.00119	CbGpPWpGaD
Timolol—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	3.17e-05	0.00119	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—AGT—dilated cardiomyopathy	3.13e-05	0.00117	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	3.12e-05	0.00117	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—ADRB1—dilated cardiomyopathy	3.07e-05	0.00115	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	3.02e-05	0.00113	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—TAZ—dilated cardiomyopathy	2.98e-05	0.00112	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—SDHA—dilated cardiomyopathy	2.93e-05	0.0011	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	2.91e-05	0.00109	CbGpPWpGaD
Timolol—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	2.86e-05	0.00107	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	2.84e-05	0.00107	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	2.76e-05	0.00103	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—SDHA—dilated cardiomyopathy	2.7e-05	0.00101	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	2.64e-05	0.000989	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.63e-05	0.000984	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	2.58e-05	0.000967	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	2.54e-05	0.000954	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	2.5e-05	0.000938	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.49e-05	0.000934	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PSEN2—dilated cardiomyopathy	2.28e-05	0.000855	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PSEN2—dilated cardiomyopathy	2.23e-05	0.000837	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.17e-05	0.000814	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.14e-05	0.000802	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	2.14e-05	0.000802	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	2.09e-05	0.000784	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—AGT—dilated cardiomyopathy	2.04e-05	0.000766	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.03e-05	0.00076	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.03e-05	0.00076	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—AGT—dilated cardiomyopathy	2e-05	0.000749	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.98e-05	0.000743	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.98e-05	0.000743	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.94e-05	0.000728	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—RAC1—dilated cardiomyopathy	1.93e-05	0.000725	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.9e-05	0.000712	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.88e-05	0.000706	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—AGT—dilated cardiomyopathy	1.86e-05	0.000696	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—AGT—dilated cardiomyopathy	1.85e-05	0.000692	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.84e-05	0.000691	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—AGT—dilated cardiomyopathy	1.82e-05	0.000681	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.79e-05	0.00067	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.79e-05	0.000669	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	1.75e-05	0.000654	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.74e-05	0.000653	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	1.66e-05	0.000623	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.57e-05	0.000588	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.56e-05	0.000584	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.52e-05	0.000571	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.49e-05	0.000558	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.48e-05	0.000554	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.29e-05	0.000483	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—RAF1—dilated cardiomyopathy	1.28e-05	0.000481	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.27e-05	0.000476	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.26e-05	0.000472	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.24e-05	0.000466	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—RAC1—dilated cardiomyopathy	1.15e-05	0.00043	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—RAC1—dilated cardiomyopathy	1.12e-05	0.000421	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—AGT—dilated cardiomyopathy	1.1e-05	0.000411	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—AGT—dilated cardiomyopathy	1.07e-05	0.000402	CbGpPWpGaD
Timolol—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.01e-05	0.000379	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—EGFR—dilated cardiomyopathy	8.84e-06	0.000331	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—EGFR—dilated cardiomyopathy	8.79e-06	0.00033	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—EGFR—dilated cardiomyopathy	8.64e-06	0.000324	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—GPX1—dilated cardiomyopathy	7.97e-06	0.000299	CbGpPWpGaD
Timolol—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	7.78e-06	0.000291	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—CD36—dilated cardiomyopathy	7.76e-06	0.000291	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—RAF1—dilated cardiomyopathy	7.61e-06	0.000285	CbGpPWpGaD
Timolol—ABCB1—Metabolism—CD36—dilated cardiomyopathy	7.57e-06	0.000284	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—RAF1—dilated cardiomyopathy	7.45e-06	0.000279	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	7.33e-06	0.000275	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	7.14e-06	0.000267	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—AGT—dilated cardiomyopathy	6.99e-06	0.000262	CbGpPWpGaD
Timolol—ABCB1—Metabolism—AGT—dilated cardiomyopathy	6.82e-06	0.000256	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	6.43e-06	0.000241	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—EGFR—dilated cardiomyopathy	5.22e-06	0.000196	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—EGFR—dilated cardiomyopathy	5.11e-06	0.000191	CbGpPWpGaD
